Javier C Angulo
Overview
Explore the profile of Javier C Angulo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
122
Citations
1138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Virseda-Chamorro M, Tellez C, Salinas-Casado J, Szczesniewski J, Ruiz-Grana S, Arance I, et al.
J Clin Med
. 2023 Dec;
12(24).
PMID: 38137573
We aimed to determine the risk factors for postoperative overactive bladder (OAB) in patients treated with an adjustable trans-obturator male system (ATOMS) for stress incontinence after radical treatment of prostate...
12.
Cilleros-Rodriguez D, Toledo-Lobo M, Martinez-Martinez D, Baquero P, Angulo J, Chiloeches A, et al.
Biochim Biophys Acta Mol Basis Dis
. 2023 Aug;
1870(1):166851.
PMID: 37611675
Protein kinase D (PKD) family members play controversial roles in prostate cancer (PC). Thus, PKD1 is nearly absent in advanced tumours, where PKD2 and PKD3 are upregulated. Additionally, consequences of...
13.
Angulo J, Tellez C, Giammo A, Gonzalez-Enguita C, Schoenburg S, Queissert F, et al.
J Clin Med
. 2023 Jul;
12(14).
PMID: 37510835
(1) Background: Treatment of male stress incontinence in patients with prostate cancer treated with radical prostatectomy and adjuvant pelvic radiation is a therapeutic challenge. The efficacy and safety of the...
14.
Sterling J, Rahman S, Varghese A, Angulo J, Nikolavsky D
J Clin Med
. 2023 Jun;
12(12).
PMID: 37373644
Radiation therapy (RT) in the management of pelvic cancers remains a clinical challenge to urologists given the sequelae of urethral stricture disease secondary to fibrosis and vascular insults. The objective...
15.
Tellez C, Szczesniewski J, Virseda-Chamorro M, Arance I, Angulo J
Curr Oncol
. 2023 May;
30(4):4153-4165.
PMID: 37185429
(1) Background: The adjustable trans-obturator male system (ATOMS) is a surgical device developed to treat post-prostatectomy incontinence (PPI) after prostate cancer treatment. We review the current literature on this anti-incontinence...
16.
Garrido-Cantero G, Longo F, Hernandez-Gonzalez J, Pueyo A, Fernandez-Aparicio T, Dorado J, et al.
Cancers (Basel)
. 2023 Mar;
15(6).
PMID: 36980640
The coronavirus disease 2019 (COVID-19) pandemic has caused a significant disruption to cancer diagnosis, treatment and prevention worldwide that could have serious consequences in the near future. We intend to...
17.
Manini C, Lopez-Fernandez E, Lopez J, Angulo J
Cancers (Basel)
. 2023 Mar;
15(5).
PMID: 36900214
This Special Issue includes 12 articles and 3 reviews dealing with several basic and clinical aspects of prostate, renal, and urinary tract cancer published during 2022 in , and intends...
18.
Zapico A, Ercilla J, Angulo J, Perez V, Cuenca J, Barreira-Hernandez D, et al.
J Clin Med
. 2023 Feb;
12(3).
PMID: 36769409
This randomized clinical trial evaluates the success rate of neuro-adaptive therapy (NAT), applied with a specific neuro-adaptive regulator device, the Self-Controlled Electro Neuro-Adaptive Regulation (SCENAR), versus a sham for urge...
19.
Orea M, Angulo J, Gonzalez-Corpas A, Echegaray D, Marva M, Lobo M, et al.
Int J Mol Sci
. 2023 Jan;
24(1).
PMID: 36614243
Castration-resistant prostate cancer (CRPC) development is the foremost concern after treatment of patients with high risk with locally advanced or metastatic prostate cancer. Androgen receptor (AR) is the main driver...
20.
Angulo J, Alvarez-Ossorio J, Dominguez-Escrig J, Moyano J, Sousa A, Fernandez J, et al.
Eur Urol Oncol
. 2022 Nov;
6(1):58-66.
PMID: 36435738
Background: Optimising therapeutic strategies of intermediate-risk non-muscle-invasive bladder cancer (IR-NMIBC) is needed. Objective: To compare recurrence-free survival (RFS) with adjuvant intravesical mitomycin C (MMC) at normothermia or hyperthermia using the...